表紙
市場調査レポート

世界のインスリンデリバリーデバイス市場:簡素化されたインスリンポンプと、低価格インスリンペンによる市場成長の促進

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

発行 GBI Research 商品コード 299030
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
世界のインスリンデリバリーデバイス市場:簡素化されたインスリンポンプと、低価格インスリンペンによる市場成長の促進 Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
出版日: 2014年04月30日 ページ情報: 英文 121 Pages
概要

世界のインスリンデリバリーデバイスの市場規模は、2012年に88億米ドル、2019年には138億米ドルに達すると予想されています。またこの間の年平均成長率(CAGR)は7%と推計されています。先進国(米国・欧州など)では、インスリンポンプの人気拡大や、人工膵臓装置などの開発・普及が市場成長の促進要因となっています。一方、新興国市場では糖尿病の有病率上昇やデリバリーデバイスの普及率の低さが、市場成長を促す要因となっています。昨今では人工膵臓装置の開発などに関する企業間の事業提携が進んでいます。今後、先進国では最新技術・装置の普及が進む一方、新興国(中国・インドなど)ではインスリンペンなどの従来型・低価格装置の普及が進んでいくものと思われます。

当レポートでは、全世界のインスリンデリバリーデバイス(インスリン注入用装置)の市場について分析し、装置の特徴・定義や最新動向、主な促進・抑制要因、全世界および主要国の市場動向(過去の実績値と今後の予測値)、主要企業のプロファイル(事業概要・上市済み製品)、現在開発中のパイプライン製品の概要、昨今の資本取引・業界再編の動きなどを調査して、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 糖尿病:疾患概要

第4章 糖尿病:疫学

第5章 インスリンデリバリーデバイスの概要

  • インスリンペン(再利用型/使い捨て型、ニードル)
  • インスリンポンプ(従来式/使い捨て型)
  • インスリンシリンジ
  • 従来式インスリンポンプの付属品
  • インスリンデリバリーデバイスの比較

第6章 市場の特徴

  • 市場収益額の実績値(過去8年間分)
  • 市場収益額の予測値(今後8年間分)
  • 主要企業の市場シェア(全世界、地域別)
  • 市場の主な傾向
    • 全自動式人工膵臓装置の開発に向けた各企業の動き
    • 事業提携による製品開発の促進
    • 即効性吸入インスリン:人工膵臓装置での利用に向けた研究
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第7章 部門別の市場分析・予測

  • インスリンペン:収益額の実績値(過去8年間分)
  • インスリンペン:収益額の予測値(今後8年間分)
  • インスリンポンプ:収益額の実績値(過去8年間分)
  • インスリンポンプ:収益額の予測値(今後8年間分)
  • インスリンシリンジ:収益額の実績値(過去8年間分)
  • インスリンシリンジ:収益額の予測値(今後8年間分)
  • 従来型インスリンポンプの付属品:収益額の実績値(過去8年間分)
  • 従来型インスリンポンプの付属品:収益額の予測値(今後8年間分)

第8章 国別の市場分析・予測

  • クロスカントリー分析
  • 各国の市場動向(金額・数量ベース、通算15年間分)
    • 米国
    • 日本
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
    • カナダ
    • 中国
    • オーストラリア
    • インド
    • ブラジル

第9章 医療費償還制度

  • 米国
  • 欧州諸国(全11ヶ国)
  • アジア太平洋地域諸国

第10章 競争環境

  • 代表的なインスリンポンプの比較:サイズ・カラーのオプション
  • 代表的なインスリンポンプの比較:ベーサル量/ボーラス量の仕様
  • 代表的なインスリンポンプの比較:ボーラス量計算機能オプションと操作法
  • Novo Nordisk(Novo A/Sの子会社)
  • Sanofi
  • Eli Lilly
  • Medtronic
  • Becton, Dickinson and Company
  • Animas
  • F. Hoffmann-La Roche
  • Insulet
  • Asante Solutions
  • Abbott Laboratories
  • Ypsomed
  • Owen Mumford
  • Bioject Medical Technologies
  • Injex - Equidyne Systems
  • Antares Pharma
  • Tandem Diabetes Care
  • Tonghua Dongbao Pharmaceutical
  • Shanghai Fosun Pharmaceutical

第11章 製品パイプラインの分析

  • パイプライン製品の一覧
    • インスリンポンプ
    • インスリンペン
  • 主なパイプライン製品のプロファイル(全36製品)

第12章 業界再編の動き

  • 資本取引のサマリー(過去10年間分)
  • 主な資本取引(過去5年間分、全7件)

第13章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Summary

GBI Research's report, "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
  • Annual market revenue data forecast to 2019 and company share data for 2012.
  • Qualitative analysis of key trends in the insulin delivery devices market.
  • Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
  • Information on reimbursement trends and market access for key countries.

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
  • Design and enhance your product development, marketing, and sales strategies.
  • Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
  • Develop market-entry and market-expansion strategies.
  • Identify the key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
  • Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.

Table of Contents

1 Table of Contents 8

  • 1.1 List of Tables 12
  • 1.2 List of Figures 14

2 Introduction 16

3 Diabetes - Disease Overview 17

  • 3.1 Types of Diabetes 17
    • 3.1.1 Type 1 Diabetes 17
    • 3.1.2 Type 2 Diabetes 17
    • 3.1.3 Gestational Diabetes 17
    • 3.1.4 Signs and Symptoms 17
    • 3.1.5 Diabetes Diagnosis 18

4 Diabetes - Epidemiology 19

5 Global Insulin Delivery Devices Market: Device Overview 20

  • 5.1 Insulin Pen 20
    • 5.1.1 Reusable Pen 20
    • 5.1.2 Disposable Pen 20
    • 5.1.3 Pen Needle 20
  • 5.2 Insulin Pump 21
    • 5.2.1 Traditional Insulin Pump 21
    • 5.2.2 Disposable Insulin Pump 21
  • 5.3 Insulin Syringe 21
  • 5.4 Traditional Insulin Pump Accessories 21
  • 5.5 Comparison of Insulin Delivery Devices 21

6 Global Insulin Delivery Devices Market: Market Characterization 23

  • 6.1 Global Insulin Delivery Devices Market, Revenue ($bn), 2005-2012 23
  • 6.2 Global Insulin Delivery Devices Market, Revenue, 2012-2019 24
  • 6.3 Insulin Delivery Devices Market, Global, Key Company Shares, 2012 25
    • 6.3.1 Global 26
    • 6.3.2 North America 26
    • 6.3.3 Europe 27
    • 6.3.4 Asia-Pacific 27
  • 6.4 Insulin Delivery Devices Market, Key Trends 27
    • 6.4.1 Companies Move Closer to Developing Fully Automated Artificial Pancreas System 28
    • 6.4.2 Collaborations Foster Innovation in Insulin Delivery Devices Market 29
    • 6.4.3 Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System 30
  • 6.5 Market Dynamics 31
    • 6.5.1 Market Drivers 31
    • 6.5.2 Market Restraints 37

7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 39

  • 7.1 Insulin Pens Market, Global, Revenue, 2005-2012 39
  • 7.2 Insulin Pens Market, Global, Revenue, 2012-2019 40
  • 7.3 Insulin Pumps Market, Global, Revenue, 2005-2012 41
  • 7.4 Insulin Pumps Market, Global, Revenue, 2012-2019 42
  • 7.5 Insulin Syringes Market, Global, Revenue, 2005-2012 43
  • 7.6 Insulin Syringes Market, Global, Revenue, 2012-2019 44
  • 7.7 Traditional Insulin Pump Accessories Market, Global, Revenue, 2005-2012 45
  • 7.8 Traditional Insulin Pump Accessories Market, Global, Revenue, 2012-2019 46

8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 47

  • 8.1 Insulin Delivery Devices Market: Cross-country Analysis 47
  • 8.2 Historic and Forecast Revenue and Volume, by Country 48
    • 8.2.1 Insulin Delivery Devices Market, US, Revenue and Volume, 2005-2019 48
    • 8.2.2 Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005-2019 51
    • 8.2.3 Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005-2019 53
    • 8.2.4 Insulin Delivery Devices Market, France, Revenue, 2005-2012 56
    • 8.2.5 Insulin Delivery Devices Market, UK, Revenue and Volume, 2005-2019 59
    • 8.2.6 Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005-2019 62
    • 8.2.7 Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005-2019 65
    • 8.2.8 Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005-2019 68
    • 8.2.9 Insulin Delivery Devices Market, China, Revenue, Volume, 2005-2019 71
    • 8.2.10 Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005-2019 74
    • 8.2.11 Insulin Delivery Devices Market, India, Revenue, 2005-2012 77
    • 8.2.12 Insulin Delivery Devices Market, Brazil, Revenue, 2005-2019 80

9 Global Insulin Delivery Devices Market: Reimbursement System 84

  • 9.1 US 84
  • 9.2 Europe 84
    • 9.2.1 Germany 84
    • 9.2.2 France 84
    • 9.2.3 Italy 84
    • 9.2.4 Spain 84
    • 9.2.5 UK 84
    • 9.2.6 Denmark 84
    • 9.2.7 Norway 85
    • 9.2.8 Sweden 85
    • 9.2.9 Belgium 85
    • 9.2.10 Netherlands 85
    • 9.2.11 Luxembourg 85
  • 9.3 Asia-Pacific 85

10 Global Insulin Delivery Devices Market: Competitive Landscape 86

  • 10.1 Comparison of Leading Insulin Pumps by Size and Color Options, 2014 86
  • 10.2 Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 87
  • 10.3 Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 88
  • 10.4 Novo Nordisk (Subsidiary of Novo A/S) 88
    • 10.4.1 Business Overview 88
    • 10.4.2 Marketed Products 89
  • 10.5 Sanofi 89
    • 10.5.1 Business Overview 89
    • 10.5.2 Marketed Products 89
  • 10.6 Eli Lilly 89
    • 10.6.1 Business Overview 89
    • 10.6.2 Marketed Products 90
  • 10.7 Medtronic 90
    • 10.7.1 Business Overview 90
    • 10.7.2 Marketed Products 90
  • 10.8 Becton, Dickinson and Company 90
    • 10.8.1 Business Overview 90
    • 10.8.2 Marketed Products 91
  • 10.9 Animas 91
    • 10.9.1 Business Overview 91
    • 10.9.2 Marketed Products 91
  • 10.10 F. Hoffmann-La Roche 91
    • 10.10.1 Business Overview 91
    • 10.10.2 Marketed Products 92
  • 10.11 Insulet 92
    • 10.11.1 Business Overview 92
    • 10.11.2 Marketed Products 92
  • 10.12 Asante Solutions 92
    • 10.12.1 Business Overview 92
  • 10.13 Abbott Laboratories 93
    • 10.13.1 Business Overview 93
    • 10.13.2 Marketed Products 93
  • 10.14 Ypsomed 93
    • 10.14.1 Business Overview 93
    • 10.14.2 Marketed Products 93
  • 10.15 Owen Mumford 94
    • 10.15.1 Business Overview 94
    • 10.15.2 Marketed Products 94
  • 10.16 Bioject Medical Technologies 94
    • 10.16.1 Business Overview 94
    • 10.16.2 Marketed Products 94
  • 10.17 Injex - Equidyne Systems 95
    • 10.17.1 Business Overview 95
    • 10.17.2 Marketed Products 95
  • 10.18 Antares Pharma 95
    • 10.18.1 Business Overview 95
    • 10.18.2 Marketed Products 95
  • 10.19 Tandem Diabetes Care 96
    • 10.19.1 Business Overview 96
    • 10.19.2 Marketed Products 96
  • 10.20 Tonghua Dongbao Pharmaceutical 96
    • 10.20.1 Business Overview 96
    • 10.20.2 Marketed Products 96
  • 10.21 Shanghai Fosun Pharmaceutical 96
    • 10.21.1 Business Overview 96
    • 10.21.2 Marketed Products 97

11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 98

  • 11.1 Insulin Delivery Devices Market: List of Pipeline Products 99
    • 11.1.1 Insulin Pumps, List of Pipeline Products 99
    • 11.1.2 Insulin Pens, List of Pipeline Products 100
  • 11.2 Insulin Delivery Devices Market: Profiles of Key Pipeline Products 100
    • 11.2.1 5th Generation CGM Sensor with t:slim Insulin Delivery System 100
    • 11.2.2 Accu-Chek Insight 100
    • 11.2.3 Angel Touch 101
    • 11.2.4 Animas Vibe Insulin Pump and CGM System 101
    • 11.2.5 Bolus Patch 101
    • 11.2.6 Cellnovo Wireless Insulin Pump System 102
    • 11.2.7 Freehand Patch Pump 102
    • 11.2.8 Insulin Pump 103
    • 11.2.9 InsuPatch Device 103
    • 11.2.10 Integrated CGM with Next Gen OmniPod System PDM 103
    • 11.2.11 Jewel Pump 104
    • 11.2.12 La Fenice E 104
    • 11.2.13 La Fenice V 105
    • 11.2.14 Lanzi 105
    • 11.2.15 Mini Pump 105
    • 11.2.16 MiniMed 640G 106
    • 11.2.17 MinIn 106
    • 11.2.18 OmniPod Insulin Pump - New Version 106
    • 11.2.19 Onetouch Ping Verio Insulin Pump with Meter Remote 107
    • 11.2.20 OneTouch with Next Gen Omnipod 107
    • 11.2.21 Patch Pump-1 107
    • 11.2.22 Patch Pump-2 108
    • 11.2.23 Patch Pump-3 108
    • 11.2.24 Spring Insulin Pump 108
    • 11.2.25 Spring Zone Hybrid Patch Pump 109
    • 11.2.26 U-Strip Insulin Patch 109
    • 11.2.27 Exenatide Once Weekly Pen Device 109
    • 11.2.28 Fix-Flex Device 110
    • 11.2.29 G-Pen 110
    • 11.2.30 G-Pen Mini 110
    • 11.2.31 Insulin Guard Self-Injector Safety Needle 111
    • 11.2.32 JuniorSTAR 111
    • 11.2.33 La Fenice Pen 111
    • 11.2.34 Levemir FlexTouch 112
    • 11.2.35 Next Generation Pen Needle II 112
    • 11.2.36 NovoLog FlexTouch 112

12 Global Insulin Delivery Devices Market: Consolidation Landscape 113

  • 12.1 Deals Summary (2004-2013) 113
  • 12.2 Key Deals (2009-2013) 113
    • 12.2.1 LifeScan Acquires Calibra Medical 113
    • 12.2.2 Roche Holding Acquires Medingo from Elron Electronic Industries, 2010 114
    • 12.2.3 Insulet Enters into Co-Development Agreement with Eli Lilly, 2013 114
    • 12.2.4 Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013 114
    • 12.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012 114
    • 12.2.6 Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012 115
    • 12.2.7 Insulet Expands Distribution Agreement with Ypsomed Holding, 2012 115

13 Appendix 116

  • 13.1 Definitions 116
    • 13.1.1 Insulin Delivery 116
  • 13.2 Abbreviations 117
  • 13.3 Bibliography 118
  • 13.4 Research Methodology 120
    • 13.4.1 Secondary Research 120
    • 13.4.2 Primary Research 120
    • 13.4.3 Models 121
    • 13.4.4 Forecasts 121
    • 13.4.5 Expert Panel 121
  • 13.5 Contact Us 121
  • 13.6 Disclaimer 121

List of Tables

  • Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013 19
  • Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012 23
  • Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019 24
  • Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 26
  • Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035 32
  • Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013 33
  • Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005-2012 39
  • Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019 40
  • Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005-2012 41
  • Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012-2019 42
  • Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005-2012 43
  • Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019 44
  • Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012 45
  • Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019 46
  • Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019 47
  • Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2012 49
  • Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012-2019 50
  • Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2005-2012 52
  • Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2012-2019 52
  • Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2012 55
  • Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2012-2019 55
  • Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2012 58
  • Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2012-2019 58
  • Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2012 61
  • Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2012-2019 61
  • Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2012 64
  • Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2012-2019 64
  • Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2012 67
  • Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2012-2019 67
  • Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2012 70
  • Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2012-2019 70
  • Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2012 73
  • Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2012-2019 73
  • Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2012 76
  • Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2012-2019 76
  • Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2005-2012 79
  • Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2012-2019 79
  • Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2012 82
  • Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2012-2019 82
  • Table 40: Novo Nordisk, Key Marketed Products, 2013 89
  • Table 41: Sanofi, Key Marketed Products, 2013 89
  • Table 42: Eli Lilly, Key Marketed Products, 2013 90
  • Table 43: Medtronic, Key Marketed Products, 2013 90
  • Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013 91
  • Table 45: Animas, Key Marketed Products, 2013 91
  • Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013 92
  • Table 47: Insulet, Key Marketed Products, 2013 92
  • Table 48: Asante Solutions, Key Marketed Products, 2013 92
  • Table 49: Abbott Laboratories, Key Marketed Products, 2013 93
  • Table 50: Ypsomed Holding AG, Key Marketed Products, 2013 93
  • Table 51: Owen Mumford, Key Marketed Products, 2014 94
  • Table 52: Bioject Medical Technologies, Key Marketed Products, 2014 94
  • Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014 95
  • Table 54: Antares Pharma, Key Marketed Products, 2014 95
  • Table 55: Tandem Diabetes Care, Key Marketed Products, 2014 96
  • Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014 96
  • Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014 97
  • Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014 99
  • Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014 100
  • Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014 100
  • Table 61: Accu-Chek Insight, Product Status, 2014 100
  • Table 62: Angel Touch, Product Status, 2014 101
  • Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014 101
  • Table 64: Bolus Patch, Product Status, 2014 101
  • Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014 102
  • Table 66: Freehand Patch Pump, Product Status, 2014 102
  • Table 67: Insulin Pump, Product Status, 2014 103
  • Table 68: InsuPatch Device, Product Status, 2014 103
  • Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014 103
  • Table 70: Jewel Pump, Product Status, 2014 104
  • Table 71: La Fenice E, Product Status, 2014 104
  • Table 72: La Fenice V, Product Status, 2014 105
  • Table 73: Lanzi, Product Status, 2014 105
  • Table 74: Mini Pump, Product Status, 2014 105
  • Table 75: MiniMed 640G, Product Status, 2014 106
  • Table 76: MinIn, Product Status, 2014 106
  • Table 77: OmniPod Insulin Pump - New Version, Product Status, 2014 106
  • Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014 107
  • Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014 107
  • Table 80: Patch Pump-1, Product Status, 2014 107
  • Table 81: Patch Pump-2, Product Status, 2014 108
  • Table 82: Patch Pump-3, Product Status, 2014 108
  • Table 83: Spring Insulin Pump, Product Status, 2014 108
  • Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014 109
  • Table 85: U-Strip Insulin Patch, Product Status, 2014 109
  • Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014 109
  • Table 87: Fix-Flex Device, Product Status, 2014 110
  • Table 88: G-Pen, Product Status, 2014 110
  • Table 89: G-Pen Mini, Product Status, 2014 110
  • Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014 111
  • Table 91: JuniorSTAR, Product Status, 2014 111
  • Table 92: La Fenice Pen, Product Status, 2014 111
  • Table 93: Levemir FlexTouch, Product Status, 2014 112
  • Table 94: Next Generation Pen Needle II, Product Status, 2014 112
  • Table 95: NovoLog FlexTouch, Product Status, 2014 112

List of Figures

  • Figure 1: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963-2011 16
  • Figure 2: Insulin Delivery Devices Market, Device Overview 20
  • Figure 3: Insulin Delivery Devices Market, Comparison of Insulin Therapy 22
  • Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012 23
  • Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019 24
  • Figure 6: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012 25
  • Figure 7: Insulin Delivery Devices Market, Market Trends 27
  • Figure 8: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas 28
  • Figure 9: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013 29
  • Figure 10: Insulin Delivery Devices Market, Market Dynamics 31
  • Figure 11: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035 31
  • Figure 12: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013 33
  • Figure 13: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps 34
  • Figure 14: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032 35
  • Figure 15: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes 36
  • Figure 16: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes 37
  • Figure 17: Insulin Pens Market, Global, Revenue ($bn), 2005-2012 39
  • Figure 18: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019 40
  • Figure 19: Insulin Pumps Market, Global, Revenue ($m), 2005-2012 41
  • Figure 20: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012-2019 42
  • Figure 21: Insulin Syringes Market, Global, Revenue ($m), 2005-2012 43
  • Figure 22: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019 44
  • Figure 23: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012 45
  • Figure 24: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019 46
  • Figure 25: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019 47
  • Figure 26: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005-2019 48
  • Figure 27: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2019 49
  • Figure 28: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005-2019 51
  • Figure 29: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005-2019 51
  • Figure 30: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005-2019 53
  • Figure 31: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2019 54
  • Figure 32: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005-2019 56
  • Figure 33: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2019 57
  • Figure 34: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005-2019 59
  • Figure 35: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2019 60
  • Figure 36: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005-2019 62
  • Figure 37: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2019 63
  • Figure 38: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005-2019 65
  • Figure 39: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2019 66
  • Figure 40: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005-2019 68
  • Figure 41: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2019 69
  • Figure 42: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005-2019 71
  • Figure 43: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2019 72
  • Figure 44: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005-2019 74
  • Figure 45: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2019 75
  • Figure 46: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005-2019 77
  • Figure 47: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('0000), 2005-2019 78
  • Figure 48: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005-2019 80
  • Figure 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2019 81
  • Figure 50: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014 86
  • Figure 51: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014 87
  • Figure 52: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014 88
  • Figure 53: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013 98
  • Figure 54: Global Insulin Delivery Devices Market, Deals Summary, 2013 113
Back to Top